Kura Oncology (KURA) Short Interest Ratio & Short Volume $6.49 -0.07 (-1.07%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$6.49 0.00 (0.00%) As of 05/1/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Kura Oncology Short Interest DataKura Oncology (KURA) has a short interest of 8.68 million shares, representing 11.81% of the float (the number of shares available for trading by the public). This marks a -1.36% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.9, indicating that it would take 5.9 days of the average trading volume of 1.15 million shares to cover all short positions.Current Short Interest8,680,000 sharesPrevious Short Interest8,800,000 sharesChange Vs. Previous Month-1.36%Dollar Volume Sold Short$52.34 millionShort Interest Ratio5.9 Days to CoverLast Record DateApril 15, 2025Outstanding Shares80,778,000 sharesShort Percent of Float11.81%Today's Trading Volume1,339,357 sharesAverage Trading Volume1,153,422 sharesToday's Volume Vs. Average116% Short Selling Kura Oncology? Sign up to receive the latest short interest report for Kura Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKURA Short Interest Over TimeKURA Days to Cover Over TimeKURA Percentage of Float Shorted Over Time Kura Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20258,680,000 shares $52.34 million -1.4%11.8%5.9 $6.03 3/31/20258,800,000 shares $58.08 million -2.4%12.0%6 $6.60 3/15/20259,020,000 shares $64.40 million -2.1%12.3%5.6 $7.14 2/28/20259,210,000 shares $71.01 million -0.4%12.5%5.6 $7.71 2/15/20259,250,000 shares $76.59 million +14.5%12.6%4.4 $8.28 1/31/20258,080,000 shares $63.91 million -0.7%12.4%3.8 $7.91 1/15/20258,140,000 shares $58.93 million -22.0%12.5%4.5 $7.24 12/31/202410,440,000 shares $90.93 million +17.4%16.0%6.3 $8.71 12/15/20248,890,000 shares $85.61 million +21.6%13.6%5.9 $9.63 11/30/20247,310,000 shares $80.70 million -33.7%11.2%5.8 $11.04 Get the Latest News and Ratings for KURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/15/202411,030,000 shares $175.60 million +2.1%17.0%10.6 $15.92 10/31/202410,800,000 shares $180.58 million +16.3%16.4%20.8 $16.72 10/15/20249,290,000 shares $169.17 million -8.8%14.3%17 $18.21 9/30/202410,190,000 shares $199.11 million -5.2%15.7%17.6 $19.54 9/30/20245,430,000 shares $1.06 million +320.9%N/A1.9 $0.20 9/15/202410,750,000 shares $224.46 million -0.5%16.6%16.9 $20.88 9/15/20241,290,000 shares $214,656.00 +8.4%N/A0.4 $0.17 8/31/202410,800,000 shares $227.45 million +3.9%16.7%16 $21.06 8/31/20241,190,000 shares $222,173.00 -22.2%N/A0.2 $0.19 8/15/202410,400,000 shares $202.28 million +12.3%16.0%14.6 $19.45 8/15/20241,530,000 shares $289,017.00 -11.1%N/A0.2 $0.19 7/31/20249,260,000 shares $192.70 million +4.0%14.3%12.5 $20.81 7/31/20241,720,000 shares $381,152.00 +74.9%N/A0.2 $0.22 7/15/20248,900,000 shares $202.65 million +1.8%13.8%12 $22.77 7/15/2024983,600 shares $279,834.20 -65.5%N/A0.1 $0.28 6/30/20248,740,000 shares $179.96 million -11.2%13.5%11.8 $20.59 6/30/20242,850,000 shares $769,785.00 +99.3%N/A0.2 $0.27 6/15/20249,840,000 shares $204.87 million -0.4%15.2%13.7 $20.82 6/15/20241,430,000 shares $262,119.00 -69.8%N/A0.1 $0.18 5/31/20249,880,000 shares $203.63 million -4.2%15.3%12.5 $20.61 5/31/20244,740,000 shares $1.47 million +319.5%N/A0.3 $0.31 5/15/202410,310,000 shares $225.48 million -0.4%16.3%12.1 $21.87 5/15/20241,130,000 shares $148,143.00 -72.0%N/A0.1 $0.13 4/30/202410,350,000 shares $203.07 million +2.3%N/A11.4 $19.62 4/30/20244,040,000 shares $627,412.00 +477.1%N/A0.3 $0.16 4/15/202410,120,000 shares $192.38 million -2.8%15.9%7.2 $19.01 4/15/2024700,000 shares $77,070.00 +6.2%N/A0.1 $0.11 3/31/202410,410,000 shares $222.05 million +1.1%16.4%7.4 $21.33 3/31/2024658,900 shares $68,525.60 -70.1%N/A0 $0.10 3/15/202410,300,000 shares $230.10 million -6.5%16.2%7.3 $22.34James Altucher: Do not invest in AI unless… (Ad)I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportunities could be even bigger.>>>See the 2 AI investing traps here now<<< 3/15/20242,200,000 shares $207,020.00 +0.5%N/A0.2 $0.09 2/29/202411,020,000 shares $232.30 million +4.9%17.4%7 $21.08 2/29/20242,190,000 shares $234,330.00 +432.7%N/A0.2 $0.11 2/15/202410,510,000 shares $215.56 million +12.2%16.3%7.1 $20.51 2/15/2024411,100 shares $44,028.81 +150.7%N/A0 $0.11 1/31/20249,370,000 shares $188.71 million No Change14.3%6.2 $20.14 1/31/2024164,000 shares $23,747.20 -59.7%5.0%0 $0.14 1/15/20249,370,000 shares $144.02 million +1.2%14.3%9.4 $15.37 1/15/2024407,100 shares $56,953.29 +234.8%12.3%0.1 $0.14 12/31/20239,260,000 shares $133.16 million -15.9%14.1%8.9 $14.38 12/31/2023121,600 shares $20,623.36 -60.4%3.7%0 $0.17 12/15/202311,010,000 shares $135.42 million -0.6%16.7%11.1 $12.30 12/15/2023306,900 shares $60,766.20 -12.8%9.3%0.3 $0.20 11/30/202311,080,000 shares $107.14 million +1.9%16.8%14.3 $9.67 11/30/2023352,000 shares $119,680.00 -34.6%10.9%0.5 $0.34 11/15/202310,870,000 shares $101.96 million +7.6%16.5%14.5 $9.38 11/15/2023538,500 shares $189,228.90 +541.8%32.3%1.3 $0.35 10/31/202310,100,000 shares $85.35 million +38.6%15.3%15.4 $8.45 10/31/202383,900 shares $62,664.91 +126.2%5.0%0.6 $0.75 10/15/20237,290,000 shares $61.53 million +4.1%11.1%11.4 $8.44 10/15/202337,100 shares $127,253.00 +152.4%2.2%2.1 $3.43 9/30/20237,000,000 shares $63.84 million +9.9%10.6%12.2 $9.12 9/30/202314,700 shares $59,388.00 +53.1%0.9%0.9 $4.04 9/15/20236,370,000 shares $63.00 million +3.8%9.7%10.3 $9.89 9/15/20239,600 shares $39,936.00 -66.6%0.6%0.1 $4.16 8/31/20236,140,000 shares $60.97 million -1.4%N/A7.8 $9.93 8/31/202328,700 shares $130,585.00 +38.0%1.8%0.2 $4.55 8/15/20236,230,000 shares $72.95 million +3.0%N/A7.2 $11.71 8/15/202320,800 shares $68,640.00 -23.3%1.2%0.1 $3.30 7/31/20236,050,000 shares $63.16 million -4.1%N/A6.8 $10.44 7/31/202327,100 shares $120,866.00 -46.6%1.6%0.2 $4.46 7/15/20236,310,000 shares $63.35 million +1.3%N/A7.1 $10.04 7/15/202350,700 shares $235,248.00 -9.8%3.1%0.3 $4.64 6/30/20236,230,000 shares $65.91 million -16.3%N/A7.2 $10.58 6/30/202356,200 shares $226,486.00 +200.5%3.4%0.3 $4.03 6/15/20237,440,000 shares $81.54 million +21.2%N/A9 $10.96 6/15/202318,700 shares $70,125.00 -26.4%1.1%0.5 $3.75 5/31/20236,140,000 shares $81.78 million -21.8%9.6%9.6 $13.32 5/31/202325,400 shares $81,534.00 +75.2%1.5%0.6 $3.21 5/15/20237,850,000 shares $99.38 million -0.4%12.4%12.5 $12.66 5/15/202314,500 shares $43,500.00 +12.4%0.9%0.3 $3.00 4/30/20237,880,000 shares $76.75 million -0.1%12.5%13.4 $9.74 4/30/202312,900 shares $35,733.00 -41.9%0.8%0.3 $2.77 4/15/20237,890,000 shares $90.26 million -3.8%12.5%12.9 $11.44 4/15/202322,200 shares $63,025.80 -12.9%1.4%0.9 $2.84 3/31/20238,200,000 shares $100.29 million +15.5%15.3%12.8 $12.23 3/31/202325,500 shares $89,989.50 +390.4%1.6%0.9 $3.53 3/15/20237,100,000 shares $83.00 million +0.1%11.0%10.6 $11.69 3/15/20235,200 shares $17,108.00 -85.4%0.3%0.1 $3.29 2/28/20237,090,000 shares $84.51 million +5.4%11.0%8.6 $11.92James Altucher: Do not invest in AI unless… (Ad)I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportunities could be even bigger.>>>See the 2 AI investing traps here now<<< 2/28/202335,600 shares $177,644.00 +65.6%2.2%0.5 $4.99 2/15/20236,730,000 shares $81.37 million +1.1%10.5%8.1 $12.09 2/15/202321,500 shares $130,075.00 +9.7%1.3%0.1 $6.05 1/31/20236,660,000 shares $92.04 million +5.4%10.3%7.5 $13.82 1/31/202319,600 shares $123,480.00 -14.4%1.2%0.1 $6.30 1/15/20236,320,000 shares $90.38 million -2.5%9.8%6.2 $14.30 1/15/202322,900 shares $162,819.00 -42.2%1.5%0.1 $7.11 12/30/20226,480,000 shares $80.42 million +2.4%10.0%6.2 $12.41 12/30/202239,600 shares $272,844.00 -56.3%2.7%0.1 $6.89 12/15/20226,330,000 shares $80.39 million -11.5%9.8%5.7 $12.70 12/15/202290,600 shares $834,426.00 -75.7%N/A0.2 $9.21 11/30/20227,150,000 shares $112.76 million +2.4%11.1%6.8 $15.77 11/30/2022373,400 shares $2.50 million +614.0%N/A1 $6.70 11/15/20226,980,000 shares $106.79 million +11.0%10.8%6.9 $15.30 11/15/202252,300 shares $208,154.00 -97.4%N/A0.9 $3.98 10/31/20226,290,000 shares $97.62 million -12.6%9.8%6.6 $15.52 10/31/20222,040,000 shares $219,708.00 +196.3%N/A0.9 $0.11 10/15/20227,200,000 shares $108.79 million -3.5%11.4%8.1 $15.11 10/15/2022688,400 shares $65,535.68 -16.8%N/A0.2 $0.10 9/30/20227,460,000 shares $101.90 million -7.8%11.8%8.4 $13.66 9/30/2022827,000 shares $89,316.00 +2.2%N/A0.3 $0.11 9/15/20228,090,000 shares $118.11 million -0.4%12.8%9.5 $14.60 9/15/2022808,900 shares $128,210.65 -11.3%N/A0.3 $0.16 8/31/20228,120,000 shares $112.54 million +4.5%12.8%10 $13.86 8/31/2022911,400 shares $141,358.14 -31.0%N/A0.3 $0.16 8/15/20227,770,000 shares $127.97 million +27.8%12.3%10 $16.47 8/15/20221,320,000 shares $245,784.00 +686.7%N/A0.4 $0.19 7/31/20226,080,000 shares $93.08 million +14.5%9.7%7.4 $15.31 7/31/2022167,800 shares $31,730.98 -56.4%N/A0 $0.19 7/15/20225,310,000 shares $95.26 million +9.3%8.4%7.1 $17.94 7/15/2022384,500 shares $94,548.55 -65.1%N/A0.1 $0.25 6/30/20224,860,000 shares $89.08 million +0.2%7.7%7.3 $18.33 6/30/20221,100,000 shares $305,800.00 +158.5%N/A0.3 $0.28 6/15/20224,850,000 shares $68.05 million +10.2%7.7%8 $14.03 6/15/2022425,500 shares $99,439.35 -35.1%N/A0.1 $0.23 5/31/20224,400,000 shares $57.90 million +7.8%7.0%7.5 $13.16 5/31/2022655,700 shares $118,026.00 +42.1%N/A0.2 $0.18 5/15/20224,080,000 shares $47.41 million +30.8%6.5%6.5 $11.62 5/15/2022461,600 shares $86,780.80 -64.5%N/A0.2 $0.19 4/30/20223,120,000 shares $44.77 million +8.7%5.0%4.2 $14.35 4/30/20221,300,000 shares $377,000.00 +157.6%N/A0.7 $0.29 4/15/20222,870,000 shares $46.29 million -1.4%4.6%3.5 $16.13 4/15/2022504,700 shares $160,999.30 +76.7%N/A0.4 $0.32 3/31/20222,910,000 shares $46.79 million -14.7%4.7%3.4 $16.08 3/31/2022285,600 shares $113,640.24 -17.5%N/A0.3 $0.40 3/15/20223,410,000 shares $51.46 million -15.6%5.5%3.9 $15.09 3/15/2022346,300 shares $107,353.00 +33.5%N/A0.7 $0.31 2/28/20224,040,000 shares $64.11 million -15.1%6.5%4.7 $15.87 2/28/2022259,400 shares $94,706.94 -59.0%N/A0.5 $0.37 2/15/20224,760,000 shares $68.07 million +24.6%7.6%4.9 $14.30James Altucher: Do not invest in AI unless… (Ad)I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportunities could be even bigger.>>>See the 2 AI investing traps here now<<< 2/15/2022633,000 shares $294,978.00 -25.4%N/A1 $0.47 1/31/20223,820,000 shares $53.82 million +15.8%6.3%4.4 $14.09 1/31/2022849,000 shares $352,335.00 -5.2%N/A1.2 $0.42 1/15/20223,300,000 shares $45.01 million +2.5%5.4%4.5 $13.64 1/15/2022895,100 shares $428,752.90 +15.6%N/A0.9 $0.48 12/31/20213,220,000 shares $45.08 million -9.0%5.2%5.1 $14.00 12/31/2021774,500 shares $394,995.00 -14.3%N/A0.5 $0.51 12/15/20213,540,000 shares $46.62 million +1.7%5.7%5.6 $13.17 12/15/2021903,500 shares $575,529.50 -15.6%N/A0.4 $0.64 11/30/20213,480,000 shares $48.58 million -7.5%5.7%5.7 $13.96 11/30/20211,070,000 shares $749,000.00 +33.8%N/A0.5 $0.70 11/15/20213,760,000 shares $65.65 million -40.8%6.1%6.1 $17.46 11/15/2021799,600 shares $699,650.00 +148.9%N/A0.4 $0.88 10/29/20216,350,000 shares $104.27 million -2.0%10.4%11 $16.42 10/29/2021321,300 shares $280,494.90 -64.6%N/A0.2 $0.87 10/15/20216,480,000 shares $116.77 million -8.0%10.6%11.7 $18.02 10/15/2021907,100 shares $784,641.50 +24.2%N/A0.6 $0.87 9/30/20217,040,000 shares $131.86 million -1.7%11.5%11.9 $18.73 9/30/2021730,500 shares $628,376.10 -30.4%N/A0.8 $0.86 9/15/20217,160,000 shares $144.49 million -21.9%11.7%10.7 $20.18 9/15/20211,050,000 shares $1.41 million -14.6%3.9%1.3 $1.34 8/31/20219,170,000 shares $169.28 million +5.8%15.0%13 $18.46 8/31/20211,230,000 shares $1.87 million -1.6%4.5%1.8 $1.52 8/13/20218,670,000 shares $143.06 million +5.4%14.2%13.6 $16.50 8/13/20211,250,000 shares $1.94 million -2.3%4.6%1 $1.55 7/30/20218,230,000 shares $155.88 million +2.2%13.3%12.1 $18.94 7/30/20211,280,000 shares $1.97 million -21.0%4.7%1 $1.54 7/15/20218,050,000 shares $148.12 million -5.5%13.0%11.9 $18.40 7/15/20211,620,000 shares $2.61 million +22.7%5.9%1.3 $1.61 6/30/20218,520,000 shares $177.64 million -0.5%13.7%12.3 $20.85 6/30/20211,320,000 shares $3.00 million +13.8%4.8%1 $2.27 6/15/20218,560,000 shares $192.60 million +1.7%13.8%12.7 $22.50 6/15/20211,160,000 shares $2.12 million -35.2%4.3%1.4 $1.83 5/28/20218,420,000 shares $187.35 million -11.3%13.6%13.4 $22.25 5/28/20211,790,000 shares $2.88 million +506.0%6.6%2.2 $1.61 5/14/20219,490,000 shares $237.25 million +1.2%N/A12.1 $25.00 5/14/2021295,400 shares $384,020.00 -43.7%1.1%0.9 $1.30 4/30/20219,380,000 shares $257.86 million +6.6%N/A12.9 $27.49 4/30/2021524,300 shares $718,291.00 -15.8%2.0%0.7 $1.37 4/15/20218,800,000 shares $256.96 million -3.8%N/A11.7 $29.20 4/15/2021622,600 shares $1.00 million +1.5%2.5%0.6 $1.61 3/31/20219,150,000 shares $243.48 million +0.6%N/A12.3 $26.61 3/31/2021613,300 shares $1.09 million -32.9%2.5%0.6 $1.77 3/15/20219,100,000 shares $268.45 million +28.2%N/A11.6 $29.50 3/15/2021914,600 shares $1.97 million +4.7%3.7%0.8 $2.15 2/26/20217,100,000 shares $190.85 million +17.0%N/A7.6 $26.88 2/26/2021873,600 shares $1.73 million -4.6%3.7%0.8 $1.98 2/12/20216,070,000 shares $212.09 million +13.9%N/A7.3 $34.94 2/12/2021915,700 shares $2.36 million +53.4%3.9%0.8 $2.58 1/29/20215,330,000 shares $167.15 million -5.2%N/A6.4 $31.36James Altucher: Do not invest in AI unless… (Ad)I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportunities could be even bigger.>>>See the 2 AI investing traps here now<<< 1/29/2021597,000 shares $1.13 million +285.4%3.3%0.7 $1.90 1/15/20215,620,000 shares $194.73 million -4.3%N/A6.7 $34.65 1/15/2021154,900 shares $215,311.00 No Change0.9%0.3 $1.39 12/31/20205,870,000 shares $199.52 million +15.8%N/A7 $33.99 12/15/20205,070,000 shares $209.59 million +8.3%N/A6.1 $41.34 11/30/20204,680,000 shares $170.26 million +8.1%N/A5.9 $36.38 11/15/20204,330,000 shares $173.03 million +25.9%N/A6 $39.96 10/30/20203,440,000 shares $109.91 million +8.5%N/A5 $31.95 10/15/20203,170,000 shares $105.97 million +5.7%N/A4.8 $33.43 9/30/20203,000,000 shares $91.92 million -22.5%N/A4.9 $30.64 9/15/20203,870,000 shares $109.64 million -5.2%N/A6.3 $28.33 8/31/20204,080,000 shares $101.55 million +3.3%N/A6.8 $24.89 8/31/2020434,400 shares $582,096.00 +32.4%N/A0.4 $1.34 8/14/20203,950,000 shares $82.91 million -1.5%N/A7 $20.99 8/14/2020328,000 shares $380,480.00 +33.0%N/A0.3 $1.16 7/31/2020246,600 shares $234,270.00 +55.7%N/A0.2 $0.95 7/31/20204,010,000 shares $65.92 million -1.5%N/A7.1 $16.44 7/15/20204,070,000 shares $72.93 million +6.8%9.7%5.4 $17.92 7/15/2020158,400 shares $107,712.00 -25.2%N/A0.2 $0.68 6/30/20203,810,000 shares $63.21 million +34.6%9.1%5.2 $16.59 6/30/2020211,700 shares $142,918.67 -53.8%N/A0.3 $0.68 6/15/20202,830,000 shares $47.83 million +2.5%6.7%3.9 $16.90 6/15/2020458,100 shares $508,491.00 +14.7%N/A0.8 $1.11 5/29/20202,760,000 shares $45.95 million -1.4%6.7%4.1 $16.65 5/29/2020399,400 shares $411,382.00 +20.3%N/A1 $1.03 5/15/20202,800,000 shares $42.84 million +2.6%6.8%4.2 $15.30 5/15/2020332,000 shares $209,359.20 +7.1%N/A1.2 $0.63 KURA Short Interest - Frequently Asked Questions What is Kura Oncology's current short interest? Short interest is the volume of Kura Oncology shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 8,680,000 shares of KURA short. 11.81% of Kura Oncology's shares are currently sold short. Learn More on Kura Oncology's current short interest. What is a good short interest ratio for Kura Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KURA shares currently have a short interest ratio of 6.0. Learn More on Kura Oncology's short interest ratio. Which institutional investors are shorting Kura Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kura Oncology: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Kura Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.81% of Kura Oncology's floating shares are currently sold short. Is Kura Oncology's short interest increasing or decreasing? Kura Oncology saw a decrease in short interest in April. As of April 15th, there was short interest totaling 8,680,000 shares, a decrease of 1.4% from the previous total of 8,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kura Oncology's short interest compare to its competitors? 11.81% of Kura Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kura Oncology: Mirum Pharmaceuticals, Inc. (16.96%), Bausch Health Companies Inc. (3.09%), Beam Therapeutics Inc. (23.74%), NewAmsterdam Pharma (8.30%), Vericel Co. (9.60%), Belite Bio, Inc (0.22%), Tarsus Pharmaceuticals, Inc. (23.89%), Janux Therapeutics, Inc. (18.91%), Schrödinger, Inc. (15.93%), Arrowhead Pharmaceuticals, Inc. (10.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Kura Oncology stock? Short selling KURA is an investing strategy that aims to generate trading profit from Kura Oncology as its price is falling. KURA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kura Oncology? A short squeeze for Kura Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KURA, which in turn drives the price of the stock up even further. How often is Kura Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KURA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies MIRM Short Interest Data BHC Short Interest Data BEAM Short Interest Data NAMS Short Interest Data VCEL Short Interest Data BLTE Short Interest Data TARS Short Interest Data JANX Short Interest Data SDGR Short Interest Data ARWR Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KURA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURA Stock Free KURA Stock Alerts